BSEBeryl Drugs LtdMinimalNeutral
Announced Mon, 13 Apr · 17:11 IST

NON- APPLICABILITY CERTIFICATE FOR THE YEAR ENDED 31st MARCH 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹23.85
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.8+6.8+1.4+3.6-1.3-9.9-16.1-11.3-1.5-5.7
Up moveDown movePending
AI summary

Beryl Drugs Ltd has filed a Non-Applicability Certificate with BSE for the year ending 31st March 2026. The actual document content was not accessible as the BSE page returned an error. Such certificates typically indicate that certain SEBI regulatory requirements (such as BRSR, related party transaction norms, or other corporate governance provisions) do not apply to the company, usually because it falls below the prescribed thresholds for applicability. This is a routine compliance filing for smaller listed companies.

Likely market impact

No immediate impact on shareholders as the certificate likely confirms the company is not subject to certain disclosure or governance requirements. This is standard procedure for smaller-cap companies.